StARD6 Activators
The indirect activators of StARD6 primarily target pathways related to lipid metabolism and cholesterol homeostasis. Statins, such as Lovastatin and Rosuvastatin, inhibit HMG-CoA reductase, a key enzyme in cholesterol biosynthesis. By influencing cholesterol synthesis, these drugs can indirectly affect the intracellular transport of cholesterol, modulating StARD6 activity.
PPARα agonists like Fenofibrate and drugs that modify cholesterol absorption or metabolism, such as Ezetimibe and Niacin, can alter the lipid profile within cells. This alteration might impact the demand for intracellular lipid transport processes in which StARD6 is involved.Bile acid sequestrants like Cholestyramine and liver X receptor (LXR) agonists (e.g., GW3965, T0901317) modulate cholesterol metabolism at different levels, influencing the function of lipid transfer proteins like StARD6. LXRs are nuclear receptors that regulate the expression of genes involved in cholesterol homeostasis, and their activation could indirectly affect StARD6 activity.SREBP (Sterol Regulatory Element-Binding Proteins) activators influence the expression of genes involved in lipid biosynthesis and metabolism. By modulating the levels of lipids and sterols in the cell, these activators could impact the functional role of StARD6. AMPK activators, such as Metformin, affect cellular energy metabolism and have been shown to influence lipid metabolic pathways. The modulation of these pathways could indirectly affect the activity of lipid transfer proteins, including StARD6.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Fenofibrate | 49562-28-9 | sc-204751 | 5 g | $41.00 | 9 | |
A PPARα agonist, influences lipid metabolism, potentially impacting StARD6 function. | ||||||
Ezetimibe | 163222-33-1 | sc-205690 sc-205690A | 25 mg 100 mg | $96.00 $241.00 | 12 | |
Inhibits intestinal absorption of cholesterol, possibly affecting StARD6 by altering cholesterol homeostasis. | ||||||
Nicotinic Acid | 59-67-6 | sc-205768 sc-205768A | 250 g 500 g | $62.00 $124.00 | 1 | |
Modulates lipid metabolism, potentially influencing StARD6 activity indirectly. | ||||||
CHOLESTYRAMINE RESIN | 11041-12-6 | sc-507509 | 5 g | $210.00 | ||
A bile acid sequestrant, affecting cholesterol metabolism and possibly StARD6 function. | ||||||
GW 3965 hydrochloride | 405911-17-3 | sc-224011 sc-224011A sc-224011B | 5 mg 25 mg 1 g | $140.00 $483.00 $3121.00 | ||
A synthetic LXR agonist, could indirectly modulate StARD6 activity via lipid metabolism. | ||||||
T 0901317 | 293754-55-9 | sc-202824 sc-202824A | 10 mg 50 mg | $89.00 $224.00 | 5 | |
Another LXR agonist, potentially impacting cholesterol transport and StARD6 function. | ||||||
1,1-Dimethylbiguanide, Hydrochloride | 1115-70-4 | sc-202000F sc-202000A sc-202000B sc-202000C sc-202000D sc-202000E sc-202000 | 10 mg 5 g 10 g 50 g 100 g 250 g 1 g | $20.00 $43.00 $63.00 $156.00 $260.00 $510.00 $31.00 | 37 | |
Influence metabolic pathways including lipid metabolism, potentially impacting StARD6. | ||||||